Atherosclerosis: Cell biology and lipoproteins-Inflammation and oxidative stress in atherogenesis: Protective role for paraoxonases

Current Opinion in Lipidology

Volumn 22, Issue 3, 2011, Pages 243-244

  Aviram, Michael ^a,b,c  

^a Lipid Research Laboratory   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 EPOXY 8,11,14 ICOSATRIENOIC ACID; ABC TRANSPORTER A1; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; VANILLOID RECEPTOR 4;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD PRESSURE; CONCENTRATION RESPONSE; CYTOLOGY; HUMAN; INFLAMMATION; NONHUMAN; NOTE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

ANIMALS; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; HUMANS; INFLAMMATION; LIPID PEROXIDATION; LIPOPROTEINS; LIPOPROTEINS, HDL; MACROPHAGES; OXIDATIVE STRESS;

EID: 79957888181     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283474beb     Document Type: Note

References (9)

1. Kaplan M, Tendler Y, Mahamid R, et al. High glucose upregulates C-reactive protein synthesis in macrophages. Clin Chem 2010; 56:1036-1038.
2. Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364:127-135.
3. D'Souza W, Stonik JA, Murphy A, et al. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein. Circ Res 2010; 107:217-227.
4. Zhao Y, Pennings M, Hildebrand RB, et al. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in bone marrow-derived cells in LDL receptor knockout mice on western-type diet. Circ Res 2010; 107:e20-e31.
5. Fuhrman B, Volkova N, Aviram M. Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients. Nutrition 2010; 26:359-366.
6. Fuhrman B, Gantman A, Aviram M. Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and conse-quently the loss of HDL cytoprotection against apoptosis. Atherosclerosis 2010; 211:61-68.
7. James RW, Brulhart-Meynet MC, Singh AK, et al. The scavenger receptor class B, type I is a primary determinant of paraoxonase-1 association with high-density lipoproteins. Arterioscler Thromb Vasc Biol 2010; 30:2121-2127.
8. Gamliel-Lazarovich A, Gantman A, Shiner M, et al. Paraoxonase 1 deficiency in mice is associated with reduced steroid biosynthesis: effects on HDL binding, cholesteryl ester accumulation and scavenger receptor type BI expression. Atherosclerosis 2010; 211:130-135.
9. Gamliel-Lazarovich A, Abassi Z, Tavori H, et al. Paroxonase1 (PON1) deficiency in mice is associated with hypotension and increased levels of the Transient Receptor Potential Vanilloid 4 (TRPV4) agonist, 5,6-epoxyeicosa- trienoic acid (5,6-EET). J Hypertension (in press).